Waters Co. (NYSE:WAT - Free Report) - Investment analysts at KeyCorp issued their FY2025 earnings per share estimates for shares of Waters in a research note issued on Monday, March 31st. KeyCorp analyst P. Knight anticipates that the medical instruments supplier will post earnings of $12.76 per share for the year. KeyCorp currently has a "Overweight" rating and a $460.00 target price on the stock. The consensus estimate for Waters' current full-year earnings is $12.86 per share.
Waters (NYSE:WAT - Get Free Report) last released its quarterly earnings data on Wednesday, February 12th. The medical instruments supplier reported $4.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.02 by $0.08. Waters had a net margin of 21.56% and a return on equity of 46.31%.
WAT has been the subject of several other research reports. UBS Group upped their target price on Waters from $405.00 to $410.00 and gave the stock a "neutral" rating in a research report on Thursday, February 13th. Bank of America decreased their price target on Waters from $430.00 to $410.00 and set a "neutral" rating for the company in a report on Thursday, February 13th. StockNews.com lowered shares of Waters from a "buy" rating to a "hold" rating in a research note on Tuesday, February 25th. JPMorgan Chase & Co. upped their target price on shares of Waters from $380.00 to $390.00 and gave the company a "neutral" rating in a research note on Thursday, March 6th. Finally, Scotiabank raised shares of Waters from a "sector perform" rating to a "sector outperform" rating and raised their price target for the company from $430.00 to $450.00 in a report on Thursday, February 13th. Ten research analysts have rated the stock with a hold rating, seven have assigned a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $401.31.
Get Our Latest Analysis on Waters
Waters Stock Down 6.0 %
Waters stock traded down $20.55 during trading on Wednesday, reaching $324.57. 933,628 shares of the company's stock were exchanged, compared to its average volume of 463,053. The company's 50-day moving average is $381.53 and its two-hundred day moving average is $373.46. The company has a debt-to-equity ratio of 1.14, a quick ratio of 0.65 and a current ratio of 0.94. Waters has a 52-week low of $279.24 and a 52-week high of $423.56. The firm has a market cap of $19.28 billion, a price-to-earnings ratio of 30.30, a PEG ratio of 3.79 and a beta of 1.04.
Institutional Inflows and Outflows
Several hedge funds have recently made changes to their positions in the company. Aster Capital Management DIFC Ltd bought a new position in Waters during the fourth quarter worth $28,000. Bank of Jackson Hole Trust acquired a new stake in shares of Waters during the fourth quarter worth $34,000. Fortitude Family Office LLC lifted its position in shares of Waters by 235.7% in the 4th quarter. Fortitude Family Office LLC now owns 94 shares of the medical instruments supplier's stock worth $35,000 after buying an additional 66 shares during the last quarter. Steward Partners Investment Advisory LLC boosted its holdings in shares of Waters by 129.3% in the 4th quarter. Steward Partners Investment Advisory LLC now owns 94 shares of the medical instruments supplier's stock valued at $35,000 after buying an additional 53 shares during the period. Finally, Murphy & Mullick Capital Management Corp bought a new stake in shares of Waters during the 4th quarter valued at about $42,000. Institutional investors and hedge funds own 94.01% of the company's stock.
About Waters
(
Get Free Report)
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
See Also
Before you consider Waters, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Waters wasn't on the list.
While Waters currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
